Cancelled | Conference Day One

8:00 am Check-In & Coffee

8:50 am Chair’s Opening Remarks

Harnessing Insights from Cell & Gene Therapy Pioneers to Optimize Medical Affairs Strategies

9:00 am Industry Leader’s Fireside Chat: Overcoming Current & Future Challenges in Cell & Gene Medical Affairs

  • Ike Ogbaa Former Vice President, Global Head of Medical Affairs, bluebird bio
  • Alexander Maurer Executive Director, WW Cell Therapy Franchise Medical Lead, Bristol Myers Squibb
  • Kent Christopherson Executive Director & Head of Global Medical Affairs, Orchard Therapeutics

Synopsis

Access session details in the full agenda.

10:00 am Morning Break & Speed Networking

Synopsis

As this community unites, this session will provide valuable networking time with your peers, enabling you to forge new and lasting connections.

Unveiling the Impact of Medical Affairs in Early-Stage Development

11:00 am Advocating for Early Integration of Medical Affairs Teams in the Pre-Launch Phase

Synopsis

Access session details in the full agenda.

11:30 am The Evolution of Medical Affairs in the Era of Cell & Gene Therapy

  • Warren Rizzo Scientific & Medical Affairs Consultant, ImmPACT Bio

Synopsis

Access session details in the full agenda.

12:00 pm Panel Discussion: Starting with the End in Mind – Investing in Medical Affairs Early to Improve Long-Term Success

  • Preeti Joshi Senior Director, Medical Affairs, BlueRock Therapeutics
  • Ike Ogbaa Former Vice President, Global Head of Medical Affairs, bluebird bio
  • Angela Tom Senior Director, Medical Affairs, Editas Medicine
  • AiThi Sprinkle Associate Director, Medical Science Liaison, Vor Bio

Synopsis

Access session details in the full agenda.

12:45 pm Lunch Break & Networking

Establishing & Maintaining a Treatment Network for a Cell & Gene Product

1:45 pm Medical Affairs Global Role in Establishing Efficient & Standardized Treatment Center Qualification

  • Katie Snell Associate Director, Global Medical Affairs, Orchard Therapeutics

Synopsis

Access session details in the full agenda.

2:15 pm Roundtable Discussion: Preparing Treatment Centers to Receive & Administer Cell & Gene Therapies

Synopsis

Access session details in the full agenda.

3:15 pm Afternoon Break & Networking

Developing a Bespoke Medical Affairs Strategy to Ensure Success in a Complex Cell & Gene Landscape

3:45 pm The Eye of the Tiger: A Focused Look into Autologous vs Allogeneic CARTs to Sharpen Medical Affairs Strategies

  • Tonia Nesheiwat Vice President, Medical Affairs & Project Leadership, Caribou Biosciences

Synopsis

Access session details in the full agenda.

4:15 pm Tailoring a Medical Strategy for Success in a Multi-CGT Landscape

  • Eileen Sawyer Former Senior Vice President, Clinical & Medical Affairs, Independent Expert

Synopsis

Access session details in the full agenda.

4:45 pm Chair’s Closing Remarks

4:50 pm End of Conference Day One